ube3a antibody (Middle Region)
Quick Overview for ube3a antibody (Middle Region) (ABIN2775648)
Target
See all ube3a AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Purpose
- UBE3A Antibody - middle region
-
Sequence
- AKNGPDTERL PTSHTCFNVL LLPEYSSKEK LKERLLKAIT YAKGFGML
-
Predicted Reactivity
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 86%
-
Characteristics
- This is a rabbit polyclonal antibody against UBE3A. It was validated on Western Blot using a cell lysate as a positive control.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human UBE3A
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
We also sell a specific blocking peptide that can be used in combination with this antibody. You can find the blocking peptide under AAP42951-100UG
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- prevent freeze-thaw cycles
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
-
- ube3a (Ubiquitin Protein Ligase E3A (ube3a))
-
Alternative Name
- UBE3A
-
Background
-
Background Information: UBE3A is an E3 ubiquitin-protein ligase, part of the ubiquitin protein degradation system. This imprinted gene is maternally expressed in brain and biallelically expressed in other tissues. Maternally inherited deletion of this gene causes Angelman Syndrome, characterized by severe motor and intellectual retardation, ataxia, hypotonia, epilepsy, absence of speech, and characteristic facies. The protein also interacts with the E6 protein of human papillomavirus types 16 and 18, resulting in ubiquitination and proteolysis of tumor protein p53.Western blots using two different antibodies against two unique regions of this protein target confirm the same apparent molecular weight in our tests.This gene encodes an E3 ubiquitin-protein ligase, part of the ubiquitin protein degradation system. This imprinted gene is maternally expressed in brain and biallelically expressed in other tissues. Maternally inherited deletion of this gene causes Angelman Syndrome, characterized by severe motor and intellectual retardation, ataxia, hypotonia, epilepsy, absence of speech, and characteristic facies. The protein also interacts with the E6 protein of human papillomavirus types 16 and 18, resulting in ubiquitination and proteolysis of tumor protein p53. Alternative splicing of this gene results in three transcript variants encoding three isoforms with different N-termini. Additional transcript variants have been described, but their full length nature has not been determined.
Gene Name: Ubiquitin protein ligase E3A
Alternative Symbols: AS, ANCR, E6-AP, HPVE6A, EPVE6AP
Protein Name: Ubiquitin-protein ligase E3A
-
Molecular Weight
- 101kDa
-
Gene ID
- 7337
-
NCBI Accession
- NP_000453
-
UniProt
- Q05086
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway
Target
-